Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?

Affiliations

¹ Department of Surgery, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool, UK Department of Radiology, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool, UK.

Comment

Fraser Mclean Smith et al. Ann Surg. 2017 Dec.

. 2017 Dec;266(6):e104-e105.

doi: 10.1097/SLA.0000000000001789.

¹ Department of Surgery, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool, UK Department of Radiology, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool, UK.

No abstract available

Comment in

Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
Battersby NJ, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Dattani M, Tekkis P, Ginnerup Pedersen B, Hagemann-Madsen GTR, Gudgeon M, Heald B, Brown G. Battersby NJ, et al. Ann Surg. 2017 Dec;266(6):e116-e118. doi: 10.1097/SLA.0000000000001791. Ann Surg. 2017. PMID: 27232254 No abstract available.

Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study.
Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, Gudgeon M, Heald B, Brown G; MERCURY II Study Group. Battersby NJ, et al. Ann Surg. 2016 Apr;263(4):751-60. doi: 10.1097/SLA.0000000000001193. Ann Surg. 2016. PMID: 25822672